HOT LINE 1 - Friday, 30 August

• HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy 
  Speaker: Marianna Fontana (University College London - London, United Kingdom of Great Britain & Northern Ireland) 
  
  
• Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control 
  Speaker: Johanne Silvain (Sorbonne University - Paris, France) 
  
  
• STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial
  Speaker: Matthieu Legrand (University of California at San Francisco - San Francisco, United States of America)  

HOT LINE 2 - Saturday, 31 August

• The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity 
  Speaker: Scott Garrison (University of Alberta - Edmonton, Canada)
  
  
• Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail 
  Speaker: Ricky Turgeon (University of British Columbia - Vancouver, Canada) 
  
  
• GMRx2 - Efficacy and safety of a novel triple single pill combination 
  Speaker: Anthony Rodgers (The George Institute for Global Health - Sydney, Australia) 
  
  
• QUADRO - A single 4-drug combination in hypertension 
  Speaker: Stefano Taddei (University of Pisa - Pisa, Italy)
  
  
• VERONICA-Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA 
  Speaker: Dike Bevis Ojji (University of Abuja - Abuja, Nigeria)  

HOT LINE 3 - Saturday 31 August

• RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure 
  Speaker: Stefan Anker (Charite University Hospital - Berlin, Germany) 
  
  
• MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation 
  Speaker: Volker Rudolph (Heart and Diabetes Center NRW - Bad Oeynhausen, Germany)
  
  
• Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation 
  Speaker: Erwan Donal (Hospital Pontchaillou of Rennes - Rennes, France)  

HOT LINE 4 - Saturday 31 August

• ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery 
  Speaker: Jung-Min Ahn (Asan Medical Center - Seoul, Korea (Republic of)
  
  
• SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting 
  Speaker: Stefan James (Uppsala University - Uppsala, Sweden)
  
  
• TIGHT-K - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery 
  Speaker: Benjamin O'Brien (Deutsches Herzzentrum der Charité - Berlin, Germany) 

HOT LINE 5 - Saturday 31 August

• NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 
  Speaker: Jacob Thomsen Loenborg (Copenhagen University Hospital - Copenhagen, Denmark)
  
  
• POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI? 
  Speaker: Dirk Jan van Ginkel (St Antonius Hospital - Nieuwegein, Netherlands (The))
  
  
• RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis 
  Speaker: Helene Eltchaninoff (University Hospital of Rouen - Rouen, France) 
  
  

HOT LINE 6 - Sunday 1 September

• STEEER-AF - Stroke prevention and rhythm control therapy 
  Speaker: Dipak Kotecha (University of Birmingham - Birmingham, United Kingdom of Great Britain & Northern Ireland)
  
  
• OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation
  Speaker: Manesh Patel (Duke University Medical Center - Durham, United States of America)
  
  
• EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease 
  Speaker: Gi-Byoung Nam (Asan Medical Center - Seoul, Korea (Republic of)) 
  
  

HOT LINE 7 - Sunday 1 September

• FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction 
  Speaker: Scott Solomon (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America) 
  
  
• MRAs in heart failure - An individual patient data meta-analysis of randomised trials
  Speaker: Pardeep Jhund (University of Glasgow - Glasgow, United Kingdom of Great Britain & Northern Ireland)
   
• FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials 
  Speaker: Muthiah Vaduganathan (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America)  
  
  

HOT LINE 8 - Sunday 1 September

• SENIOR RITA - Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction 
  Speaker: Vijay Kunadian (Newcastle University - Newcastle-Upon-Tyne, United Kingdom of Great Britain & Northern Ireland) 
  
  
• EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients 
  Speaker: Gianluca Campo (University Hospital of Ferrara - Ferrara, Italy) 
  
  
• SCOFF - Fasting or no fasting before cardiac catherisation procedures 
  Speaker: David Ferreira (John Hunter Hospital - Newcastle, Australia)
  
  

HOT LINE 9 - Sunday 1 September

• STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-old 
  Speaker: Katrin Kemp Gudmundsdottir (Karolinska Institutet Danderyd Hospital - Stockholm, Sweden)
  
  
• GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals 
  Speaker: Renato Lopes (Duke University Medical Center - Durham, United States of America) 
  
  
• MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China 
  Speaker: Minglong Chen (The First Affiliated Hospital of Nanjing Medical University - Nanjing, China) 
  
  

HOT LINE 10 - Monday 2 September

• SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation 
  Speaker: Rajdip Dulai (University College London - London, United Kingdom of Great Britain & Northern Ireland)
   
• SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation 
  Speaker: Masaharu Masuda (Kansai Rosai Hospital - Amagasaki, Japan)
  
  
• CRABL-HF - Cryoballoon vs. Radiofrequency Ablation of AF in Patients with Heart Failure 
  Speaker: Kengo Kusano (National Cerebral and Cardiovascular Center Hospital - Osaka, Japan) 

HOT LINE 11 - Monday 2 September

• OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions 
  Speaker: Kim Byeong-Keuk (Severance Cardiovascular Hospital, Yonsei University College of Medicine - Seoul, Korea (Republic of)) 
  
  
• INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes 
  Speaker: David Erlinge (Lund University - Lund, Sweden) 
  
  
• REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions: a multicenter, non-inferiority trial 
  Speaker: Ling Tao (Xijing Hospital of the Fourth Military Medical University - Xi'an, China) 

HOT LINE 12 - Monday 2 September

• PROTEUS - A prospective randomised controlled trial evaluating the use of artificial intelligence in stress echocardiography 
  Speaker: Ross Upton (University of Oxford - Oxford, United Kingdom of Great Britain & Northern Ireland) 
  
  
• RAPIDxAI - Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using artificial intelligence
  Speaker: Derek Chew (Victorian Heart Hospital - Melbourne, Australia)  FlindersHeart
  
  
• WESTCOR-POC - Point of care versus centralised high-sensitivity cardiac troponin in the emergency department 
  Speaker: Viola Thulin (Haukeland University Hospital - Bergen, Norway)